Physician Assistant, Medical · Danvers, MA
NPI
1669825493
Since 2016
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
480 Maple St
Danvers, MA, 01923
Phone (978) 304-8451
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
604 services
Medicare patients, 2024
207
Average age 72
Drug cost, 2024
$2.6M
4,581 prescriptions
Company payments, 2024
$143
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justine N Yeo was code 99214 (office e&m - established), 400 times for 173 patients. In total Justine N Yeo billed 604 services in 10 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 400 | 173 | $59.20 | $24K |
| 95251 Test - Miscellaneous | Office | 117 | 54 | $21.87 | $2,559 |
| 99204 Office E&M - New | Office | 33 | 33 | $76.83 | $2,536 |
| 99215 Office E&M - Established | Office | 31 | 25 | $91.27 | $2,829 |
By year: 2023 $9,607 for 162 services; 2024 $33K for 604 services.
Medicare prescription drug claims, 2024
In 2024, the drug Justine N Yeo prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 484 prescriptions and refills. In total Justine N Yeo wrote 4,581 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 484 | 637 | 89 | $660K |
| Ozempic Semaglutide | 411 | 653 | 100 | $607K |
| Metformin Hcl Er Metformin Hcl | 348 | 871 | 104 | $6,136 |
| Levothyroxine Sodium Generic | 335 | 955 | 126 | $3,742 |
| Jardiance Empagliflozin | 233 | 503 | 64 | $274K |
| Trulicity Dulaglutide | 215 | 294 | 53 | $284K |
| Metformin Hcl Generic | 154 | 414 | 53 | $1,838 |
| Tresiba Flextouch U-100 Insulin Degludec | 150 | 342 | 46 | $114K |
| Atorvastatin Calcium Generic | 146 | 357 | 60 | $1,740 |
| Glipizide Er Glipizide | 114 | 261 | 30 | $2,816 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 109 | 275 | 42 | $14K |
| Rosuvastatin Calcium Generic | 95 | 258 | 35 | $2,239 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 87 | 245 | 36 | $9,326 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 86 | 212 | 29 | $46K |
| Lisinopril Generic | 80 | 208 | 36 | $774 |
Brand drugs: 2,300 claims; generic drugs: 1,991 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Justine N Yeo $143 ($143 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $143.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.